Enanta Pharmaceuticals (ENTA) shares rallied 13.8% in the last trading session to close at $12.04. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Enanta Pharmaceuticals (NASDAQ:ENTA) gains attention after new coverage, reflecting Nasdaq index biotech movement.
It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though ...
Shares of Enanta Pharmaceuticals (ENTA) have gained 5.1% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term ...
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Investors are always looking for stocks that are poised to beat at earnings season and Enanta Pharmaceuticals, Inc. ENTA may be one such company. The firm has earnings coming up pretty soon, and ...
Detailed price information for Enanta Pharmaceutica (ENTA-Q) from The Globe and Mail including charting and trades.